formoterol   Click here for help

GtoPdb Ligand ID: 3465

Synonyms: BD-40A | CGP-25827A | Foradil® | Oxeze/Oxis® | YM-08316
Approved drug Immunopharmacology Ligand
formoterol is an approved drug (FDA (2001))
Compound class: Synthetic organic
Comment: Formoterol is a long-acting inhalation bronchodilator. The approved drug is a racemic mixture of enantiomers; PubChem lists 6 CIDs as isotopes of this molecule. We show the non-chiral molecule here to represent the mixture. The marketed formulation may contain formoterol fumarate (PubChem CID 9912089). Arformoterol is the (R,R)-enantiomer of formoterol.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 4
Rotatable bonds 9
Topological polar surface area 90.82
Molecular weight 344.17
XLogP 2.21
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O
Isomeric SMILES O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O
InChI InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)
InChI Key BPZSYCZIITTYBL-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
β2-adrenoceptor Hs Agonist Agonist 5.6 – 8.6 pKi - 6,10-12
⤷ pKi 5.6 – 8.6 [6,10-12]
β1-adrenoceptor Hs Agonist Agonist 5.8 – 6.5 pKi - 6-7,9-10,12
⤷ pKi 5.8 – 6.5 [6-7,9-10,12]
β3-adrenoceptor Hs Agonist Agonist 5.0 – 5.8 pKi - 5-6,8,10
⤷ pKi 5.0 – 5.8 [5-6,8,10]
β2-adrenoceptor Primary target of this compound Hs Agonist Agonist 8.6 – 10.1 pEC50 - 1,6-8,12
⤷ pEC50 8.6 – 10.1 [1,6-8,12]
β1-adrenoceptor Hs Agonist Agonist 8.3 – 9.4 pEC50 - 4,6-7,12
⤷ pEC50 8.3 – 9.4 [4,6-7,12]
β3-adrenoceptor Hs Agonist Agonist 7.6 – 9.2 pEC50 - 2-3,6,8,13
⤷ pEC50 7.6 – 9.2 [2-3,6,8,13]
Ligand mentioned in the following text fields